We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Insys Therapeutics, Inc. | NASDAQ:INSY | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.2911 | 0.30 | 0.315 | 0 | 01:00:00 |
Date: | Tuesday, Oct. 2, 2018 | |
Time: | 1:05 p.m. Eastern Time | |
Location: | New York, N.Y. |
The presentation will be webcast live at the aforementioned time, and archived for 90 days thereafter, via the Investors section of company’s website at https://www.insysrx.com/, under Presentations & Events. Accessible at the same webpage, the presentation slides will be available during and after the conference.
About INSYS
INSYS Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve patients’ quality of life. Using proprietary spray technology and capabilities to develop pharmaceutical cannabinoids, INSYS is developing a pipeline of products intended to address unmet medical needs and the clinical shortcomings of existing commercial products. INSYS is committed to developing medications for potentially treating anaphylaxis, epilepsy, Prader-Willi syndrome, opioid addiction and overdose, and other disease areas with a significant unmet need.C
CONTACT: | Corporate Communications | Investor Relations |
Joe McGrath | Jackie Marcus or Chris Hodges | |
INSYS Therapeutics | Alpha IR Group | |
480-500-3101 | 312-445-2870 | |
jmcgrath@insysrx.com | INSY@alpha-ir.com |
1 Year INSYS THERAPEUTICS, INC. Chart |
1 Month INSYS THERAPEUTICS, INC. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions